Employing the latest innovations is enabling our in-house new product development and manufacturing to grow at scale. When combined with our commercialization prowess and round-the-clock delivery, scientists are ensured rapid access to the newest and best proteomic research tools available globally.
With application across discovery research, diagnostics and therapeutic development, our products are accelerating the pace of life science research and improving the efficiency of experimental and diagnostic workflows.
Antibodies are proteins made by the body when exposed to unknown foreign substances, such as viruses. They are recognizable by their distinctive Y-shape and each antibody binds to a very specific part of the foreign substance, known as an antigen.
Developing a high-performance antibody with the desired features, such as specificity (the ability of an antibody to bind only to its target protein) and affinity (the strength with which an antibody binds to its target protein) and consistency, is challenging. To do this efficiently at scale requires extensive protein and cell-engineering skills and know-how.